Second, our experimental validation primarily involved differential expression and in vitro verification of the cancer-promoting functions of JAM-A, leaving out the underlying mechanisms and specific processes through which JAM-A regulates cancer progression, such as variation and methylation patterns, immune infiltration, and other tumor-associated functions, which demand further experimentation in vivo and in vitro. This evidence concerns the gene F11R and cancer.